Eli Lilly's combination antibody therapy for COVID-19 cuts risk of hospitalization and death by 87%

The combination therapy from from Eli Lilly & Corecognizes the coronavirus and attaches to it, which blocks the pathogen from entering cells and spreading throughout the body.

from Health News | Mail Online https://ift.tt/3bEo2Nj

Comentarii

Postări populare de pe acest blog

Telehealth hubs offer care options for people living on the edge the virtual world

Overuse on cattle feedlots is a key factor in antibiotic resistance, report says

Bringing Your Ballpark Food Favorites Home